I’m not seeing any real substance in Cosette allegations, so far they’re all speculative and no real impact on the company finance. Mayne had a letter from FDA on 1 product but that is it, and come on it’s one speaker’s presentation! What are they going to do? I’d seen people making up a lot more shit in conferences all the time.
I think Mayne response is fair and justified. I don’t think the fall in sp is due to that letter, it’s the leak about Cosette walking away. UBS which advices Cosette been the one selling.
I’m not seeing any real substance in Cosette allegations, so far...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.06 |
Change
-0.140(2.69%) |
Mkt cap ! $406.2M | |||
| Open | High | Low | Value | Volume |
| $5.19 | $5.19 | $4.97 | $431.9K | 85.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 833 | $5.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.06 | 459 | 3 |
View Market Depth
| Last trade - 12.10pm 16/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |